Literature DB >> 20186700

Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma.

Kalu U E Ogbureke1, Rafik A Abdelsayed, Harvey Kushner, Li Li, Larry W Fisher.   

Abstract

BACKGROUND: : Patients with oral premalignant lesions (OPL) present with oral squamous cell carcinomas (OSCC) at a much higher rate than the general population. There are currently no useful markers that indicate specifically which OPLs are most likely to progress. Three small integrin binding ligands N-linked glycoprotein (SIBLING) family proteins, bone sialoprotein (BSP), osteopontin (OPN), and dentin sialophosphoprotein (DSPP), have been shown to be up-regulated in many cancers, including OSCC. The status of SIBLING expression in OPLs and their correlation to transition to oral cancer are unknown.
METHODS: : Sixty archival surgical biopsies of dysplastic OPLs were evaluated by immunohistochemistry for expression of BSP, DSPP, and OPN and correlated with local transformation to OSCC at sites adjacent to surgically removed dysplastic OPL.
RESULTS: : The OPL patient population was representative of previous studies with 20% progressing to OSCC, and no correlation between degree of dysplasia and progression. Eighty-seven percent were positive for at least 1 SIBLING protein. OPN expression had no correlation with progression. The BSP+/DSPP- expression pattern however correlated with decreased transformation to OSCC (point prevalence = 0%; 95% confidence interval [CI], 0-20.6), whereas the BSP-/DSPP+ pattern was associated with more frequent progression (point prevalence = 77.8%; 95%CI, 47.8-95.4). Incrementally higher expression scores (0 to 3) of BSP and DSPP were also associated with increased predictive values (odds ratio, 25.53; 95% CI, 2.14-304.7 and 10.13; 95% CI, 2.0-50.0, respectively, for each increment).
CONCLUSIONS: : BSP and DSPP are excellent candidate markers for successful OPL surgical intervention and may be predictors of OPL-OSCC progression. Cancer 2010. (c) 2010 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186700      PMCID: PMC2847022          DOI: 10.1002/cncr.24938

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality.

Authors:  T Saito; C Sugiura; A Hirai; K Notani; Y Totsuka; M Shindoh; H Fukuda
Journal:  Int J Oral Maxillofac Surg       Date:  2001-02       Impact factor: 2.789

2.  Diagnosis of early oral and oropharyngeal squamous carcinoma: obstacles and their amelioration.

Authors:  A Mashberg
Journal:  Oral Oncol       Date:  2000-05       Impact factor: 5.337

Review 3.  ABC of oral health. Swellings and red, white, and pigmented lesions.

Authors:  C Scully; S Porter
Journal:  BMJ       Date:  2000-07-22

4.  Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity.

Authors:  W W Jiang; H Fujii; T Shirai; H Mega; M Takagi
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

5.  Erythroplakia of the oral cavity.

Authors:  W G Shafer; C A Waldron
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

6.  Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias.

Authors:  C A Waldron; W G Shafer
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

7.  Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions.

Authors:  Martial Guillaud; Lewei Zhang; Catherine Poh; Miriam P Rosin; Calum MacAulay
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

8.  Expression of SIBLINGs and their partner MMPs in salivary glands.

Authors:  K U E Ogbureke; L W Fisher
Journal:  J Dent Res       Date:  2004-09       Impact factor: 6.116

Review 9.  Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics.

Authors:  Jesper Reibel
Journal:  Crit Rev Oral Biol Med       Date:  2003

10.  Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins.

Authors:  Larry W Fisher; Neal S Fedarko
Journal:  Connect Tissue Res       Date:  2003       Impact factor: 3.417

View more
  19 in total

1.  Cancer Secretome May Influence BSP and DSP Expression in Human Salivary Gland Cells.

Authors:  Samantha Lynn Hamilton; Blake Ferando; Asha Sarah Eapen; Jennifer Chian Yu; Anita Rose Joy
Journal:  J Histochem Cytochem       Date:  2016-11-25       Impact factor: 2.479

2.  DMP-1 promoter-associated antisense strand non-coding RNA, panRNA-DMP-1, physically associates with EGFR to repress EGF-induced squamous cell carcinoma migration.

Authors:  Shigeki Suzuki; Hang Yuan; Shizu Hirata-Tsuchiya; Kazuma Yoshida; Akiko Sato; Eiji Nemoto; Hideki Shiba; Satoru Yamada
Journal:  Mol Cell Biochem       Date:  2021-01-09       Impact factor: 3.396

3.  A novel auditory ossicles membrane and the development of conductive hearing loss in Dmp1-null mice.

Authors:  Kun Lv; Haiyang Huang; Xing Yi; Mark E Chertoff; Chaoyuan Li; Baozhi Yuan; Robert J Hinton; Jian Q Feng
Journal:  Bone       Date:  2017-06-08       Impact factor: 4.398

4.  Oral dysplasia: biomarkers, treatment, and follow-up.

Authors:  Paul Nankivell; Hisham Mehanna
Journal:  Curr Oncol Rep       Date:  2011-04       Impact factor: 5.075

5.  Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2.

Authors:  Rajeshree Joshi; Amany Tawfik; Nneka Edeh; Veronica McCloud; Stephen Looney; Jill Lewis; Stephen Hsu; Kalu U E Ogbureke
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

Review 6.  OPN -Revisited.

Authors:  Vijayanirmala Subraman; Muthukumar Thiyagarajan; N Malathi; Sharada T Rajan
Journal:  J Clin Diagn Res       Date:  2015-06-01

7.  Targeting of chemoprevention to high-risk potentially malignant oral lesions: challenges and opportunities.

Authors:  Victor D Martinez; Calum E MacAulay; Martial Guillaud; Wan L Lam; Lewei Zhang; Kitty K Corbett; Miriam P Rosin
Journal:  Oral Oncol       Date:  2014-09-16       Impact factor: 5.337

8.  Expression of Osteopontin in Oral Squamous Cell Carcinoma and its Surgical Margins-An Immunohistochemical Study.

Authors:  Vijaya Nirmala Subramani; Malathi Narasimhan; Muthukumar Thiyagarajan; Balu David Munuswamy; Logeswari Jayamani
Journal:  J Clin Diagn Res       Date:  2015-11-01

9.  Whole Exome Sequencing of Highly Aggregated Lung Cancer Families Reveals Linked Loci for Increased Cancer Risk on Chromosomes 12q, 7p, and 4q.

Authors:  Anthony M Musolf; Bilal A Moiz; Haiming Sun; Claudio W Pikielny; Yohan Bossé; Diptasri Mandal; Mariza de Andrade; Colette Gaba; Ping Yang; Yafang Li; Ming You; Ramaswamy Govindan; Richard K Wilson; Elena Y Kupert; Marshall W Anderson; Ann G Schwartz; Susan M Pinney; Christopher I Amos; Joan E Bailey-Wilson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-12-11       Impact factor: 4.254

10.  Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing.

Authors:  Winnie S Liang; David W Craig; John Carpten; Mitesh J Borad; Michael J Demeure; Glen J Weiss; Tyler Izatt; Shripad Sinari; Alexis Christoforides; Jessica Aldrich; Ahmet Kurdoglu; Michael Barrett; Lori Phillips; Hollie Benson; Waibhav Tembe; Esteban Braggio; Jeffrey A Kiefer; Christophe Legendre; Richard Posner; Galen H Hostetter; Angela Baker; Jan B Egan; Haiyong Han; Douglas Lake; Edward C Stites; Ramesh K Ramanathan; Rafael Fonseca; A Keith Stewart; Daniel Von Hoff
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.